Update on the Treatment of Glucocorticoid-Induced Osteoporosis
Osteoporosis and osteoporotic fracture are one of the most common side effects of glucocorticoid therapy. All patients who are taking any dose of glucocorticoids for over 3 months should have a bone health assessment. After consideration of their clinical risk factors, glucocorticoid dose, bone mine...
Main Authors: | Ai Lee Lim, Swan Sim Yeap |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2022-06-01
|
Series: | Journal of Clinical Rheumatology and Immunology |
Subjects: | |
Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341722300038 |
Similar Items
-
An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosis, 2015
by: Swan Sim Yeap, et al.
Published: (2017-03-01) -
Update on Glucocorticoid Induced Osteoporosis
by: Soo-Kyung Cho, et al.
Published: (2021-06-01) -
Glucocorticoid-induced osteoporosis: 2013 update
by: M. Mazzantini, et al.
Published: (2014-07-01) -
REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
by: N. V. Toroptsova
Published: (2018-05-01) -
Osteoporosis inducidapor glucocorticoides
by: Maria Lorena Brance, et al.
Published: (2014-09-01)